Alphatec Holdings (ATEC) Consolidated Net Income (2010 - 2026)
Alphatec Holdings (ATEC) reported Consolidated Net Income of -$33.9 million for Q1 2026, up 34.68% on a YoY basis from -$25.2 million in Q1 2025, and down 128.56% sequentially from $118.7 million in Q4 2025.
Alphatec Holdings (ATEC) Consolidated Net Income (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Consolidated Net Income data on file, last reported at -$33.9 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income rose 34.68% year-over-year to -$33.9 million; the trailing twelve-month figure through Mar 2026 stood at $15.1 million (up 109.08% YoY), and the FY2025 full-year result was -$2.9 million, up 98.21% from the prior year.
- Consolidated Net Income eased to -$33.9 million in Q1 2026, from $118.7 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $118.7 million in Q4 2025 to a low of -$51.9 million in Q1 2025.
- A 5-year average of -$31.1 million and a median of -$40.5 million in 2023 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income tumbled 86.07% in 2022 and soared 450.02% in 2025, its largest moves.
- Tracing ATEC's Consolidated Net Income over 5 years: stood at -$34.8 million in 2022, then fell by 16.37% to -$40.5 million in 2023, then increased by 16.2% to -$33.9 million in 2024, then soared by 450.02% to $118.7 million in 2025, then tumbled by 128.56% to -$33.9 million in 2026.
- Business Quant data shows ATEC's Consolidated Net Income at -$33.9 million in Q1 2026, $118.7 million in Q4 2025, and -$28.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | -33.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.91 Mn |
| Dec 31, 2025 | 118.72 Mn |
| Sep 30, 2025 | -28.58 Mn |
| Jun 30, 2025 | -41.14 Mn |
| Mar 31, 2025 | -51.91 Mn |
| Dec 31, 2024 | -33.92 Mn |
| Sep 30, 2024 | -39.62 Mn |
| Jun 30, 2024 | -40.68 Mn |
| Mar 31, 2024 | -48.50 Mn |
| Dec 31, 2023 | -40.48 Mn |
| Sep 30, 2023 | -42.65 Mn |
| Jun 30, 2023 | -51.38 Mn |
| Mar 31, 2023 | -43.53 Mn |
| Dec 31, 2022 | -34.78 Mn |
| Sep 30, 2022 | -36.79 Mn |
| Jun 30, 2022 | -37.10 Mn |
| Mar 31, 2022 | -42.62 Mn |
| Dec 31, 2021 | -40.38 Mn |
| Sep 30, 2021 | -43.03 Mn |
| Jun 30, 2021 | -38.21 Mn |